LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,507,000 | +2.8% | 11,108 | +108.0% | 0.59% | +56.3% |
| Q3 2018 | $1,466,000 | +208.0% | 5,341 | +85.0% | 0.38% | +514.8% |
| Q1 2018 | $476,000 | -52.9% | 2,887 | -60.9% | 0.06% | -54.5% |
| Q4 2017 | $1,011,000 | -28.5% | 7,387 | -28.9% | 0.13% | -28.0% |
| Q3 2017 | $1,413,000 | +97.9% | 10,385 | +76.5% | 0.19% | +104.4% |
| Q2 2017 | $714,000 | -64.3% | 5,883 | -68.8% | 0.09% | -64.3% |
| Q1 2017 | $1,998,000 | -65.6% | 18,886 | -67.0% | 0.26% | -50.7% |
| Q4 2016 | $5,807,000 | -17.1% | 57,158 | -16.8% | 0.52% | -5.7% |
| Q3 2016 | $7,009,000 | +31.3% | 68,677 | +53.4% | 0.55% | +38.0% |
| Q2 2016 | $5,338,000 | +11.2% | 44,756 | -0.2% | 0.40% | +16.1% |
| Q1 2016 | $4,801,000 | +105.3% | 44,838 | +107.9% | 0.34% | +111.1% |
| Q4 2015 | $2,338,000 | – | 21,567 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |